Zynerba (ZYNE) stock forecast for 2024

The forecast has been updated: December 1, 2022 7:37


Zynerba stock price online today

Analyst Target Price

6.44

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $6.44 target price for Zynerba stock stock.

Today 200 Day Moving Average is the resistance level (1.25 $).

50 Day Moving Average is the support level (0.702 $).




ZYNE Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 0.96 0.88 1.10 20.14 %
Feb 0.94 0.82 0.97 15.46 %
Mar 1.04 1.00 1.10 8.72 %
Apr 1.19 1.06 1.29 17.79 %
May 1.13 1.07 1.26 14.85 %
Jun 1.14 1.05 1.29 18.61 %
Jul 1.28 1.14 1.42 19.53 %
Aug 1.10 1.03 1.21 14.83 %
Sep 0.94 0.81 1.07 24.62 %
Oct 0.88 0.76 0.96 20.41 %
Nov 0.92 0.81 0.99 17.52 %
Dec 1.07 0.97 1.12 13.69 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.


Zynerba overview

Zynerba Address

80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US

Market Capitalization

26 359 800 $

EBITDA

-35 174 184

PE Ratio

None

PEG Ratio

0

Dividend Per Share

0

Dividend Yield

0

EPS

-0.962

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

-

Forward PE

-

EV To Revenue

397.61

EV To EBITDA

0.781

52 Week High

3.61

52 Week Low

0.5

50 Day Moving Average

0.702

200 Day Moving Average

1.25

Shares Outstanding

47062700

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Zynerba stock forecast for this year


Zynerba stock forecast for Jan 2024.
Estimated Average Forecasted Zynerba Price: 0.96. Positive monthly dynamics of the instrument is expected with 20.140% volatility is expected.

Pessimistic forecast: 0.88

Optimistic: 1.10


Zynerba stock forecast for Feb 2024.
Estimated Average Forecasted Zynerba Price: 0.94. Negative monthly dynamics of the instrument is expected with 15.463% volatility is expected.

Pessimistic forecast: 0.82

Optimistic: 0.97


Zynerba stock forecast for Mar 2024.
Estimated Average Forecasted Zynerba Price: 1.04. Positive monthly dynamics of the instrument is expected with 8.725% volatility is expected.

Pessimistic forecast: 1.00

Optimistic: 1.10


Zynerba stock forecast for Apr 2024.
Estimated Average Forecasted Zynerba Price: 1.19. Positive monthly dynamics of the instrument is expected with 17.787% volatility is expected.

Pessimistic forecast: 1.06

Optimistic: 1.29


Zynerba stock forecast for May 2024.
Estimated Average Forecasted Zynerba Price: 1.13. Negative monthly dynamics of the instrument is expected with 14.849% volatility is expected.

Pessimistic forecast: 1.07

Optimistic: 1.26


Zynerba stock forecast for Jun 2024.
Estimated Average Forecasted Zynerba Price: 1.14. Positive monthly dynamics of the instrument is expected with 18.614% volatility is expected.

Pessimistic forecast: 1.05

Optimistic: 1.29


Zynerba stock forecast for Jul 2024.
Estimated Average Forecasted Zynerba Price: 1.28. Positive monthly dynamics of the instrument is expected with 19.526% volatility is expected.

Pessimistic forecast: 1.14

Optimistic: 1.42


Zynerba stock forecast for Aug 2024.
Estimated Average Forecasted Zynerba Price: 1.10. Negative monthly dynamics of the instrument is expected with 14.832% volatility is expected.

Pessimistic forecast: 1.03

Optimistic: 1.21


Zynerba stock forecast for Sep 2024.
Estimated Average Forecasted Zynerba Price: 0.94. Negative monthly dynamics of the instrument is expected with 24.623% volatility is expected.

Pessimistic forecast: 0.81

Optimistic: 1.07


Zynerba stock forecast for Oct 2024.
Estimated Average Forecasted Zynerba Price: 0.88. Negative monthly dynamics of the instrument is expected with 20.413% volatility is expected.

Pessimistic forecast: 0.76

Optimistic: 0.96


Zynerba stock forecast for Nov 2024.
Estimated Average Forecasted Zynerba Price: 0.92. Positive monthly dynamics of the instrument is expected with 17.522% volatility is expected.

Pessimistic forecast: 0.81

Optimistic: 0.99


Zynerba stock forecast for Dec 2024.
Estimated Average Forecasted Zynerba Price: 1.07. Positive monthly dynamics of the instrument is expected with 13.686% volatility is expected.

Pessimistic forecast: 0.97

Optimistic: 1.12



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.07 (04.11.2022) 1.68 %
AbbVie Inc.
ABBV 145.28 (04.11.2022) 0.60 %
Aeterna Zentaris Inc.
AEZS 4.01 (04.11.2022) 2.82 %
Allakos Inc.
ALLK 5.99 (04.11.2022) 5.83 %
Allogene Therapeutics, Inc.
ALLO 9.34 (04.11.2022) -1.89 %
Amgen Inc.
AMGN 269.04 (04.11.2022) 1.19 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.75 (04.11.2022) 2.15 %
Aurora Cannabis Inc.
ACB 1.31 (04.11.2022) -5.07 %
Becton Dickinson and Company
BDX 220.84 (04.11.2022) -0.07 %
Biogen Inc.
BIIB 281.82 (04.11.2022) 0.56 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 15.47 (04.11.2022) 4.60 %
BioNTech SE
BNTX 154.31 (04.11.2022) 6.24 %
bluebird bio, Inc.
BLUE 6.13 (04.11.2022) -2.23 %
Boston Scientific Corp.
BSX 41.59 (04.11.2022) 0.14 %
Bristol-Myers Squibb Company
BMY 78.78 (04.11.2022) 0.38 %
Canopy Growth Corp.
CGC 3.29 (04.11.2022) -4.64 %
Castle Biosciences, Inc.
CSTL 21.94 (04.11.2022) -9.60 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 19.96 (04.11.2022) 2.20 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 8.32 (04.11.2022) 4.92 %
Gilead Sciences, Inc.
GILD 80.34 (04.11.2022) 1.11 %
GlaxoSmithKline plc
GSK 32.99 (04.11.2022) 0.46 %
GoodRx Holdings, Inc.
GDRX 5.06 (04.11.2022) 3.27 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.3 (04.11.2022) 0.52 %
Inovio Pharmaceuticals, Inc.
INO 2.11 (04.11.2022) -1.40 %
Johnson & Johnson
JNJ 171.48 (04.11.2022) 0.45 %
Medtronic plc.
MDT 84.65 (04.11.2022) 0.75 %
Merck & Co., Inc.
MRK 99.2 (04.11.2022) 0.46 %
Moderna, Inc.
MRNA 158.41 (04.11.2022) 7.40 %
Novartis AG
NVS 81.72 (04.11.2022) 1.67 %
Novavax, Inc.
NVAX 19.4 (04.11.2022) -3.82 %
ObsEva SA
OBSV 0.1688 (04.11.2022) 0.60 %
OrganiGram Holdings Inc.
OGI 0.9738 (04.11.2022) 0.11 %
Pfizer Inc.
PFE 47.22 (04.11.2022) 1.40 %
Regeneron Pharmaceuticals, Inc.
REGN 740.21 (04.11.2022) 0.21 %
Sanofi
SNY 43.62 (04.11.2022) 1.82 %
Schrodinger, Inc.
SDGR 20.92 (04.11.2022) -15.17 %
Senseonics Holdings, Inc.
SENS 1.18 (04.11.2022) -0.84 %
Sorrento Therapeutics, Inc.
SRNE 1.46 (04.11.2022) -1.35 %
Stryker Corp.
SYK 210.98 (04.11.2022) 2.66 %
Sundial Growers Inc.
SNDL 2.32 (04.11.2022) -2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.47 (04.11.2022) -1.63 %
Thermo Fisher Scientific Inc.
TMO 495.55 (04.11.2022) 1.77 %
Tilray, Inc.
TLRY 3.81 (04.11.2022) -0.26 %
UnitedHealth Group, Inc.
UNH 538.17 (04.11.2022) -1.00 %
Veeva Systems Inc.
VEEV 166.81 (04.11.2022) -0.20 %
Zomedica Corp.
ZOM 0.2245 (04.11.2022) -2.01 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.7051 (04.11.2022) -2.07 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.